Phytopharm plc (PYM.L)
-LSE 1.26 
0.06(4.64%) May 17, 4:15AM EDT
| Prev Close: | 1.33 |
|---|
| Open: | 1.26 |
|---|
| Bid: | 1.32 |
|---|
| Ask: | 1.34 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.25 - 1.40 |
|---|
| 52wk Range: | 1.02 - 12.98 |
|---|
| Volume: | 169,770 |
|---|
| Avg Vol (3m): | 1,200,540 |
|---|
| Market Cap: | 4.38M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 24,557.56 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | -1.95 |
|---|
| Quarterly EPS Est
(Mar-13)
: | N/A |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | -0.03 |
|---|
Business Summary
Phytopharm plc, a development stage pharmaceutical company, develops novel treatments targeting diseases with high levels of unmet need. The companys lead compounds include Cogane and Myogane, which are orally bioavailable neurotrophic facto...
View More